Delic Holdings Corp (CSE: DELC | OTCQB: DELCF | FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to share the following corporate update:
- Delic Corp released its first annual end-of-year earnings report in May. In 2021 the Company generated more than USD$1.5MM in revenue and increased net assets to USD$10MM in 2021 from USD$2.1MM in 2020, a 500% YoY improvement.
- Ketamine Wellness Centers (KWC) currently has 13 operational, state-of-the-art clinics that accept insurance and they are approaching 100,000 treatments to clinically eligible patients.
- On April 1, KWC officially began offering SPRAVATO®, the FDA-approved esketamine nasal spray covered by some insurance, at its Houston, Las Vegas and Seattle locations and quickly expanded to include the Minneapolis, Salt Lake City and Dallas clinics with more on the way.
- KWC introduced NAD+ infusion therapy at six of its clinic locations—Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson—with plans to expand nationwide.
- KWC announced a new partnership with the Veterans Administration (VA) in Arizona. This new VA partnership is in addition to the VA partnership established with the KWC located in Burnsville, Minnesota.
- KWC launched the Ketamine Wellness Integrative Therapist Directory, connecting KWC patients with qualified mental health practitioners.
Delic announced its first annual earnings for 2021 and reported revenue in excess of USD$1.5MM and increased net assets from USD$2.1MM in 2020 to USD$10MM. Delic continues to focus on accelerating growth through the expansion of its national chain of Ketamine Wellness Centers (KWC) and the addition of numerous new programs and services.
KWC is on track to reach 100,000 treatments to clinically eligible patients and began servicing more patients than any other ketamine provider with SPRAVATO® at the Houston, Las Vegas and Seattle locations on April 1. The FDA-approved esketamine nasal spray is covered by some insurance carriers and patients can work with the experienced insurance team at KWC to assist them in determining their coverage and potential out-of-pocket costs for the treatment. KWC Minneapolis, Salt Lake City and Dallas became the latest locations to offer the treatment to their patient base.
KWC also introduced NAD+ therapy as a treatment option. The therapy is administered intravenously or intramuscularly (IM) and has the potential to boost natural energy stores and immunity, brain and DNA function, and cell communication when a patient is successfully treated, along with enhancing the process of healing chronic conditions such as depression, PTSD and anxiety.
Building on their initial partnership with the Veterans Administration (VA) at the clinic located in Burnsville, MN, KWC secured a new partnership with the VA to support veterans suffering from treatment-resistant depression, PTSD and anxiety in Arizona. Veterans in search of mental health treatment now have access to ketamine therapy at the Phoenix, Tucson and Mesa-Gilbert locations at no out-of-pocket cost with prior authorization from the VA. Lastly, KWC launched the Ketamine Wellness Integrative Therapist Directory, a comprehensive resource connecting KWC patients with qualified mental health practitioners who can help them process and integrate the benefits of ketamine therapy into their everyday life. The Directory is available to anyone visiting the KWC website.
Matt Stang, Co-founder and CEO of Delic, commented: “I’m very excited to say Delic Corp is thriving and continuing to grow as evidenced by the revenue we generated in our first full year of operation. We have a strong team across all the businesses and I’m proud of the work we have done so far to make these life-changing therapies more affordable and accessible, while also working to change the perception of psychedelics and mental health. However, there are still too many people suffering with mental health conditions who are not aware of the help available to them right now. We will continue to find solutions to these challenges and make sure the treatments are more affordable and everyone who needs these therapies has access to them.”
About Delic
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The Company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, Ketamine Wellness Centers; the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and effective treatment options to the masses.